Relenza And Tamiflu May Add Only 10[cents] PMPM Annually For HMOs, Study Says
Executive Summary
The new influenza treatments Relenza and Tamiflu could cost managed care organizations a yearly estimated average of 10[cents] per member per month if visits for influenza do not increase, an Advance Paradigm study projects.